USPTO serial 79294719
Serial No. 79294719
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 6, 2021
- Examiner
- SHANAHAN, PATRICK
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with Serial No. 79294719?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Ningbo Liwah Pharmaceutical Co., Ltd.
CN
Other trademarks owned by Ningbo Liwah Pharmaceutical Co., Ltd.
Ningbo Liwah Pharmaceutical Co., Ltd.
CN
Other trademarks owned by Ningbo Liwah Pharmaceutical Co., Ltd.
Ningbo Liwah Pharmaceutical Co., Ltd.
CN
Other trademarks owned by Ningbo Liwah Pharmaceutical Co., Ltd.
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines for human purposes, namely, medicines for intestinal disorders, antiallergic medicines and rheumatoid arthritis, and medicines for dental purposes; chemico-pharmaceutical preparations for the treatment of cardiovascular diseases, Alzheimer disease, hypertension and rheumatoid arthritis; pharmaceutical preparations for the treatment of cardiovascular diseases, Alzheimer disease, hypertension and rheumatoid arthritis; drugs for medical purposes, namely, drugs for intestinal disorders, drugs for antiallergic disorders, drugs for dental purposes and rheumatoid arthritis; medicinal herbs; antibiotics; traditional Chinese medicinal herbs; biochemical medicines, namely, medicines for intestinal disorders, antiallergic medicines, medicines for dental purposes and rheumatoid arthritis; chemical preparations for medical purposes, namely, for intestinal disorders, antiallergic and rheumatoid arthritis, and for dental purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Ningbo Liwah Pharmaceutical Co., Ltd.
- Other trademarks owned by Ningbo Liwah Pharmaceutical Co., Ltd.
- Other trademarks owned by Ningbo Liwah Pharmaceutical Co., Ltd.
- Other trademarks in Class 005
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 6, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 7, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 7, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 7, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 8, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 19, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 19, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 6, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 6, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 24, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 19, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 19, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 30, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 30, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 30, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 11, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 22, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 18, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 18, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 18, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 5, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 5, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 16, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 15, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 9, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 7, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 5, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 1, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |